Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BATMAN: Alendronate for Bone Health in Breast Cancer
NCT00122356Phase 3Completed
- Sponsor
- Barwon Health
- Start
- Sep 2005
- Primary completion
- Feb 2013
- Countries
- 1
01
Overview
Phase 3, open-label trial of alendronate in osteoporosis, sponsored by Barwon Health. Primary endpoint: Bone Mineral Density T-score at 5 years. Started Sep 2005; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00122356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122356.